Literature DB >> 31308868

Decreased Odds for Vasospasm Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage after Transitioning from Neurosurgery Led Care to a Neurology Led Multidisciplinary Approach.

Russell Bartt1,2, Stephanie Jarvis3, Lauren Cittadino2, Benjamin Atchie2, Kathryn McCarthy2, Rebecca van Vliet2, Alicia Bennett1,2, Jeffrey Wagner1,2, Alessandro Orlando3, David Bar-Or3.   

Abstract

INTRODUCTION: The limited research on the management of aneurysmal subarachnoid hemorrhages (aSAHs) has not assessed the efficacy of neurology-led care. Our objective was to describe aSAH patients' outcomes after transitioning from a neurosurgery-led intensive care unit (ICU) to a neurology-led multidisciplinary care neurocritical care unit (NCCU). The study hypothesis was that the neurology-led multidisciplinary care would improve patient outcomes.
METHODS: This was a retrospective cohort study. We included patients (≥ 18) with aSAHs from 1/16 to 8/16 (pregroup) and from 3/17 to 11/17 (postgroup). The pregroup care was led by a neurosurgeon. The postgroup care included a neurologist, a pulmonary intensivist, a neurocritical care clinical nurse specialist, a neurosurgeon, and euvolemia protocol. The primary outcome was trips to interventional radiology (IR) for vasospasm treatment. Univariate analyses and multivariable ordinal logistic regression were used.
RESULTS: There were 99 patients included: 50 in the pregroup and 49 in the postgroup. On average, postgroup patients were 7 years older than the pregroup (p = 0.05); no other demographic or clinical characteristics significantly differed. The 62% higher number of trips to IR for vasospasm treatment, when compared to the pregroup, p < 0.001.
CONCLUSIONS: In aSAH patients, the neurology-led multidisciplinary care in the NCCU decreased the odds of repeated procedures for vasospasm treatment. Neurology-led multidisciplinary care could be more cost-effective than the neurosurgical-led care.

Entities:  

Year:  2019        PMID: 31308868      PMCID: PMC6613482     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  13 in total

1.  The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial.

Authors:  Adib A Abla; David A Wilson; Richard W Williamson; Peter Nakaji; Cameron G McDougall; Joseph M Zabramski; Felipe C Albuquerque; Robert F Spetzler
Journal:  J Neurosurg       Date:  2013-12-06       Impact factor: 5.115

2.  Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage.

Authors:  Owen Samuels; Adam Webb; Steve Culler; Kathleen Martin; Daniel Barrow
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

3.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

4.  Improvement in intensive care unit outcomes in patients with subarachnoid hemorrhage after initiation of neurointensivist co-management.

Authors:  S Andrew Josephson; Vanja C Douglas; Michael T Lawton; Joey D English; Wade S Smith; Nerissa U Ko
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

5.  Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Authors:  Tyree H Kiser
Journal:  Hosp Pharm       Date:  2014-11

6.  Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.

Authors:  Mervyn D I Vergouwen; Marinus Vermeulen; Jan van Gijn; Gabriel J E Rinkel; Eelco F Wijdicks; J Paul Muizelaar; A David Mendelow; Seppo Juvela; Howard Yonas; Karel G Terbrugge; R Loch Macdonald; Michael N Diringer; Joseph P Broderick; Jens P Dreier; Yvo B W E M Roos
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

Review 7.  Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.

Authors:  Jan W Dankbaar; Arjen Jc Slooter; Gabriel Je Rinkel; Irene C van der Schaaf
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

8.  Impact of neurointensivist-managed intensive care unit implementation on patient outcomes after aneurysmal subarachnoid hemorrhage.

Authors:  Satoshi Egawa; Toru Hifumi; Kenya Kawakita; Masanobu Okauchi; Atsushi Shindo; Masahiko Kawanishi; Takashi Tamiya; Yasuhiro Kuroda
Journal:  J Crit Care       Date:  2015-12-02       Impact factor: 3.425

9.  The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage.

Authors:  Leonie Jestaedt; Mirko Pham; Andreas J Bartsch; Ekkehard Kunze; Klaus Roosen; László Solymosi; Martin Bendszus
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

Review 10.  Management of delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Charles L Francoeur; Stephan A Mayer
Journal:  Crit Care       Date:  2016-10-14       Impact factor: 9.097

View more
  1 in total

1.  Neurocritical Care: A Growing International Collaborative.

Authors:  Andreas H Kramer; Philippe Couillard
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.